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The SV40 large T-antigen (TAg) has proven useful in studying pathways involved with cell division and tissue homeostasis.
TAg disrupts the normal action of tumor suppressors pRb and p53. It is unclear whether T-antigen inhibition of p53 and pRb
is sufficient for oncogenic transformation or if additional T-antigen activities are required. To pursue this question, cell lines
were generated that coexpress an amino-terminal fragment of T-antigen (TAgN136), which has been shown to be sufficient
to block pRb function, together with a dominant-negative p53. Neither focus formation nor saturation density was enhanced
by coexpression of the dominant-negative p53 molecule, p53DD, along with TAgN136. Furthermore, a full-length TAg mutant
incapable of binding p53 was capable of relieving contact inhibition, a hallmark of transformation. These results suggest the
presence of a novel transforming activity in addition to the binding and inactivation of p53, requiring TAg amino acids 137 to
708. © 2001 Academic Press
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Every viral genome is constantly subjected to the ulti-
mate functional genomics screen—that of natural selec-
tion. Thus the successful viral proteome represents a
unique and powerful set of completed target validation
experiments. The study of cellular pathways targeted by
viral proteins is validated by the survival and fitness of the
viral genome. For example, targets of various tumor virus
oncoproteins have proven to be key components of cellular
pathways regulating cell division and tissue homeostasis
(reviewed by zur Hausen, 1999). Recently, known and un-
known targets of the simian virus 40 large T-antigen (TAg)
were shown to be among those forming a minimum com-
plement of biochemical pathways the disruption of which is
sufficient for oncogenic transformation of normal human
cells (Hahn et al., 1999). Viewed from this perspective, the
discovery of any novel transforming activity in a viral onco-
protein such as T-antigen has a high probability of revealing
some aspect of cellular transformation.
Transforming activities have been mapped to specific
regions of the TAg polypeptide by measuring various as-
pects of the transformed phenotype elicited by wild-type
and mutant TAg molecules. Such aspects include immor-
talization of primary cells (Tevethia et al., 1998), relief from
contact inhibition of cellular division at confluence (Price et
al., 1994), abnormally high saturation density (Tevethia et al.,
1997), the formation of dense foci (Srinivasan et al., 1997),
and in vivo studies of neoplastic conversion using trans-
genic mice (reviewed by Stappenbeck et al., 1998).
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40Amino- and carboxy-terminal transforming activities
can act independently, as demonstrated in studies in
which coexpression of two separate TAg fragments
(amino acids 1 to 147 of TAg and amino acids 251 to 708)
resulted in immortalization of primary cells at an effi-
ciency comparable with that of full-length TAg (Tevethia
et al., 1998). Amino-terminal activities include the binding
and inactivation of tumor suppressor pRb (reviewed by
Livingstone, 1992) as well as a DnaJ chaperone-like
activity (reviewed by Brodsky and Pipas, 1998). A frag-
ment of TAg comprising only amino acids 251 to 708 was
shown to cooperate with an activated ras oncogene to
form dense foci in primary rat embryo fibroblasts (Cav-
ender et al., 1995). An essential role for carboxy-terminal
regions of TAg during transformation was demonstrated
in studies using transgenic mice expressing wild-type
and mutant TAgs in the small intestine (Kim et al., 1994).
Whereas full-length wild-type TAg induced intestinal dys-
plasia, expression of amino-terminal fragments resulted
in only hyperplasia (Kim et al., 1994). Furthermore, amino-
terminal fragments of SV40 TAg have been shown to be
either impaired or completely deficient for transformation
in dense focus assays using either C3H 10T1/2 cells or
REF52 cells, respectively (Srinivasan et al., 1997). Car-
boxy-terminal regions of TAg responsible for binding and
inactivating tumor suppressor p53 function (Kierstead
and Tevethia, 1993) are among those absent from amino-
terminal fragments in studies cited above. These find-
ings suggest an important role for p53 in tumor suppres-
sion. However, they also raise the question of whether
p53 is the only cellular target of full-length TAg left unal-
tered by amino-terminal TAg fragments.
In this study, we examined the hypothesis that cellular
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41T-ANTIGEN, DOMINANT-NEGATIVE p53, TRANSFORMATIONp53 is the sole target for the carboxy terminus of TAg
during transformation by using cells expressing both
dominant-negative mutant p53DD and TAg amino-termi-
nal fragment TAgN136. As a truncation mutant compris-
ing only the wild-type p53 oligomerization domain,
p53DD disrupts normal p53 transcriptional transactiva-
tion functions by forming inactive heterooligomers with
endogenous full-length p53 (Shaulian et al., 1992, 1995).
If p53 is the sole target of TAg amino acids 137 to 708,
then transformation in the presence of p53DD should be
as efficient for TAg p53 binding mutants as for wild-type
TAg.
RESULTS
The T-antigen LXCXE motif is not sufficient for high
saturation density
In order to further investigate defects in transformation
by amino-terminal TAg fragments, the saturation densi-
ties of stable cell lines expressing TAg (10T TAg) and TAg
mutants (N136 and N136-3213) were studied. Mutant
N136 comprises the first 136 amino acids of wild-type
T-antigen (Srinivasan et al., 1997). N136-3213 is identical
to N136 except that it encodes two point mutations
(E107K, E108K) in the TAg LXCXE motif required for bind-
ing and inactivation of tumor suppressor pRb (DeCaprio
et al., 1988). C3H10T1/2 cells were transfected and se-
lected for antibiotic resistance, and expression of the
transfected genes was verified by immunoblotting and
immunofluorescence (Fig. 3 and data not shown). Two
days after reaching confluence, cells were fixed and
stained with DNA-specific dye Hoechst 33258. As seen
FIG. 1. The T-antigen LXCXE motif is insufficient for high saturation
ensity. C3H10T1/2 cells expressing a neomycin resistance gene (A),
ild-type SV40 T-antigen (B), TAgN136-3213 (C), and TAgN136 (D) were
ixed and stained with DNA-specific dye Hoechst 33258 two days after
eaching confluence. Microphotographs of stained nuclei were mader
s
sing UV ilumination. The arrowhead in B indicates a mitotic figure. Bar,
0 mm.in Fig. 1, the saturation density of 10T TAg cells was
dramatically higher than that of control cells transfected
with empty vector alone (10T). In at least 10 independent
experiments, cells expressing wild-type TAg, reached a
minimum twofold increase over normal, contact-inhibited
saturation densities of approximately 5 3 104 cells per
quare centimeter. A complete loss of contact inhibition
n 10T TAg cells was indicated by the presence of meta-
hase mitotic figures (see arrowhead in Fig. 1). After
pproximately 3 days of postconfluent culture, cells ex-
ressing full-length TAg supersaturated the culture ves-
el, as indicated by a precipitous drop in culture medium
H (data not shown).
Typical of cells experiencing a pRb-dependent G1/S
ell-cycle block (Liu and Preisig, 1999; Rao, 1999), nuclei
n contact-inhibited cells expressing no TAg (10T) or
AgN136-3213 were larger than nuclei of cells express-
ng an intact TAg LXCXE pRb-binding motif and J-domain
Fig. 1). The relatively normal saturation density of
AgN136 cells indicates a requirement for full-length TAg
n achieving the high saturation density characteristic of
ransformed cells.
ull-length T-antigen promotes three-dimensional
rowth above a confluent monolayer
High saturation density (see Fig. 1) could arise either
rom increased packing of cells in a single layer or from
n increased capacity for detachment from the culture
ubstratum and growth above the monolayer. The nature
f the high saturation phenomenon was studied using
hree-dimensional confocal microscopic images taken
rom saturated cultures of cells expressing full-length
Ag and TAgN136. Figure 2 displays optical slices taken
n the X-Y plane of saturated cultures of cells. This view
ffers a cross-sectional or “top-to-bottom” picture of the
FIG. 2. Stacking of cells expressing full-length SV40 T-antigen. Two
days after reaching confluence, C3H10T1/2 cells expressing wild-type
TAg and T-antigen mutant N136 were fixed, treated with RNase, and
stained with propidium iodide. Stained nuclei were visualized in two
planes by laser scanning confocal microscopy. Arrows indicate two
nuclei above the plane of the confluent monolayer. Bar, 1 mm.elative position of nuclei in cells at postconfluent den-
ity. Two days after reaching confluence, cells were
42 SACHSENMEIER AND PIPASstained with nucleic acid-specific dye propidium iodide
following fixation and RNase treatment. Nuclei in a plane
above that of the confluent monolayer were visible only
in cells expressing full-length T-antigen compared with
10TN136 or control C3H10T1/2 cells (Fig. 2). These re-
sults demonstrate a role for TAg amino acids 137 to 708
in promoting growth above that of the saturated mono-
layer characteristic of contact-inhibited cells.
p53DD fails to enhance saturation density of cells
expressing p53-binding mutants of T-antigen
Regions in the carboxyl half of the TAg polypeptide
required to bind and inactivate tumor suppressor p53 are
not present in amino-terminal fragment N136. We hypoth-
esized that if p53 was the sole target of TAg amino acids
137–708, then the failure of 10TN136 cells to reach high
saturation density would be complemented by a domi-
nant-negative p53 mutant. Stable C3H10T1/2 cell lines
were made expressing full-length TAg, fragment N136,
as well as p53DD alone or in combination with TAgN136.
Lines were also made expressing a full-length p53-bind-
ing mutant TAg, 5031. TAg mutant 5031 contains three
point mutations (D402N, V404N, V413M) in the TAg p53-
binding region that abolish p53 binding and inactivation
(Peden et al., 1998). Expression of wild-type p53 and
p53DD was confirmed by immunofluorescence and im-
munoblotting as shown in Fig. 3. The inhibitory activity of
mutant p53DD upon endogenous wild-type p53 was in-
dicated by a dramatic reduction in steady state levels of
the p53-dependent protein p21 (Fig. 3). TAg and mutant
TAg expression in the same cells and lysates was also
confirmed and expression was shown by immunofluo-
rescence for at least 70% of the cells for each line (data
not shown). As expected, full-length p53 was only detect-
able in cells in which its normally rapid turnover was
stabilized by wild-type TAg (Fig. 3).
The ability of p53DD to overcome contact inhibition
and increase the saturation density of 10TN136 cells was
measured by trypsinizing and counting the number of
cells present for each cell line 2 days after reaching
confluence. As shown in Fig. 4, p53DD achieved only a
modest increase in 10TN136 saturation density. Further-
more, full-length TAg mutant 5031 was able to overcome
contact inhibition, resulting in a saturation density com-
parable with that of wild-type TAg, despite its inability to
bind or stabilize p53.
p53DD promotes attachment but not survival of cells
expressing TAg fragment N136
Cell death and/or detachment to the culture medium
might account for the low saturation density of 10TN136
cells. Detached or dead cells would not be detectable in
the assays described above. Therefore, cell death and
detachment phenomena were studied by counting the
total number of cells (i.e., attached and detached) ascells reached and passed confluence and by measuring
their colony-forming efficiency.
Two days after reaching confluence, C3H10T1/2 cells
expressing either wild-type TAg, N136, 5031, and p53DD
alone or in combination were trypsinized and counted.
Culture medium was not changed during the 2-day pe-
riod but was collected and concentrated and the fraction
of detached cells was calculated as a percentage of the
total number attached and detached. Data presented in
Fig. 5 show a dramatic difference in the fraction of cells
detached between 10TN136 cells and all other cells
examined. Similar detachment was also seen in BALB/c
3T3 cells expressing the identical oncoproteins (data not
shown). This difference increased linearly until cells
expressing full-length TAg supersaturated the culture
vessel.
Interestingly, detachment of cells expressing both
TAgN136 and p53DD was strikingly reduced compared
with that of cells expressing TAgN136 alone. p53DD
reduced the fraction of detached 10TN136 cells approx-
imately fivefold (Fig. 5), suggesting a need for p53 inac-
tivation in promoting cell attachment during transforma-
tion by T-antigen.
To examine the potential contribution of p53-depen-
FIG. 3. Expression of p53DD in C3H10T1/2 cells. C3H10T1/2 cells
were stably transfected with genomic clones of a p53DD, TAg, TAg
amino-terminal fragment N136 alone, or p53DD and empty vector DNA
as a control. Following G418 selection, cells were screened for expres-
sion of the transfected oncoproteins. For immunofluorescence (A), cells
were cultured on coverslips, fixed, and incubated with anti-p53 mono-
clonal antibody 421. For immunoblotting (B), equal amounts of TX100
soluble protein were resolved on a 12% SDS–PAGE gel, transferred to
a membrane, and probed with monoclonal antibody 421. Similar immu-
noblots, including a positive control of purified p21, were probed with
anti-p21 antibody in C.dent apoptosis to the low saturation density and high
rate of postconfluent detachment, the colony-forming ef-
enden
n
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43T-ANTIGEN, DOMINANT-NEGATIVE p53, TRANSFORMATIONficiency of cells expressing TAgN136 and p53DD was
measured and compared to that of control cells. Cells
expressing TAgN136 showed only a slight difference in
colony-forming efficiency compared with those express-
ing p53DD alone or TAgN136 in addition to p53DD (Fig.
6). Cells expressing full-length TAg were approximately
twice as efficient at colony formation as the other lines
tested, with the exception of 10T5031, which showed an
intermediate survival rate (Fig. 6). Similar results were
obtained using cells that had spontaneously detached
during postconfluent culture (data not shown). These
results indicate that the presence of an apoptotic sub-
FIG. 4. p53DD fails to enhance saturation density of cells expressi
indicated oncoproteins or a neomycin resistance gene alone were cu
hemacytometer. Error bars represent the standard error of three indep
FIG. 5. p53DD promotes the attachment of cells expressing TAg mut
eomycin resistance gene were cultured two days past confluence. Attan the culture medium were concentrated and counted. The percentage of cells
Error bars represent the standard error of three independent experiments.population unique to cells expressing TAgN136, either
adherent or detached, cannot be detected by a differ-
ence in colony-forming efficiency.
p53DD fails to enhance focus formation by TAg
amino-terminal fragment N136 and
full-length TAg mutant TAg5031
In order to confirm the failure of p53DD to enhance
transformation by TAg p53-binding mutants, a different
assay of in vitro transformation was used. Dense focus
formation assays were performed using REF52 cells, in
-binding mutants of T-antigen. C3H10T1/2 cells stably expressing the
2 days past confluence. Cells were trypsinized and counted using a
t experiments.
6. C3H10T1/2 cells stably expressing the indicated oncoproteins or a
ells were trypsinized and counted using a hemacytometer. Cells foundng p53
lturedant N13
ched cdetached was calculated as [detached/(detached 1 attached)] 3 100.
o
1
t
eprese
w
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44 SACHSENMEIER AND PIPASwhich TAgN136 and TAg5031 are incapable of focus
formation (Srinivasan et al., 1997). As a less stringent test
f focus formation, C2H10T1/2 cells, which show only a
0% focus-forming efficiency compared with that of wild-
ype TAg (Srinivasan et al., 1997), were used. Cells were
transfected with equal amounts of plasmid containing
genomic clones of full-length TAg, TAgN136, TAg5031,
p53DD, or a combinations of p53DD with either TAgN136
FIG. 6. p53DD fails to promote survival of cells expressing TAg m
expressing the indicated oncoproteins or a neomycin resistance gene
replated at various dilutions and cultured for 8 to 10 days. The resulting
capable of forming colonies was expressed as a percentage of the
necessarily at the plating density optimal for colony counting. Data are r
the standard error of triplicate plates.
FIG. 7. p53DD fails to enhance focus formation by TAg amino-termina
containing genomic clones of wild-type TAg, TAgN136, TAg5031, p53DD
transfection, cells were split onto triplicate plates and cultured for 6 (REere then fixed and stained and dense foci were counted. Examples of d
orphology. Numbers in parentheses are counts from triplicate wells and aror TAg5031. Following transfection, cells were split into
triplicate vessels for a focus assay as described under
Materials and Methods. As shown in Fig. 7, p53DD nei-
ther complemented the deficiency of TAgN136 for focus
formation in REF52 cells nor enhanced the ability of
TAgN136 or TAg5031 to induce foci at wild-type TAg
efficiency in C3H10T1/2 cells. Transfection of empty neo-
mycin vector plasmid DNA failed to yield foci in either
N136. Two days after reaching confluence, C3H10T1/2 cells stably
rypsinized and counted. An equal number of cells from each line was
es were fixed, stained, and counted, and the fraction of surviving cells
lated. Stained colonies from each cell line are shown, although not
ntative of at least three independent experiments. Error bars represent
ent N136. REF52 and C3H10T1/2 cells were transfected with plasmids
mbinations of p53DD with either TAgN136 or 5031. Two days following
75-cm2 flasks) or 3 (C3H10T1/2 in 3.5-cm diameter plates) weeks. Cellsutant
were t
coloni
cells pl fragm
, and co
F52 inense foci are shown without magnification for comparison of focus
e representative of at least three independent experiments.
45T-ANTIGEN, DOMINANT-NEGATIVE p53, TRANSFORMATIONcell line, and stable expression of the transfected pro-
teins was confirmed by immunoblotting and immunoflu-
orescence (Fig. 3 and data not shown).
DISCUSSION
Experiments reported here suggest the presence of a
novel carboxy-terminal transforming activity of TAg, in
addition to the binding and inactivation of p53. They
preclude an essential role for cellular p53 as the sole
cellular target of the carboxyl half of SV40 large T-antigen
during transformation in vitro. Despite the presence of
intact pRb-binding and chaperone-like DnaJ domains,
amino-terminal TAg fragment N136 failed to induce high
saturation density, consistent with its previously pub-
lished (Srinivasan et al., 1997) deficiency in dense focus
formation. This failure is demonstrated to arise, in part,
from the detachment of cells expressing TAgN136 from
the culture dish after overcoming contact inhibition.
Dominant-negative mutant p53DD was capable of reduc-
ing cellular detachment when coexpressed with
TAgN136 but not capable of inducing saturation densi-
ties comparable with those achieved by either wild-type
TAg or a full-length p53-binding mutant of TAg, TAg5031.
Furthermore, the possible contribution of p53-dependent
apoptosis in reducing the transformation efficiency of
TAgN136 was ruled out by experiments showing compa-
rable colony-forming efficiencies between cells express-
ing TAgN136 and TAgN136 along with p53DD. Finally, a
combination of p53 and TAgN136 or TAg5031 was not
able to enhance the ability of these mutants to form
dense foci.
Two possible mechanisms that could account for the
apparent low saturation density (Fig. 2) and reduced
focus-forming ability of TAgN136 (Srinivasan et al., 1997)
were studied: contact inhibition and TAgN136-induced
cell death. Simple contact inhibition in cells expressing
TAg amino-terminal fragment N136 is curious given that
it contains the two amino-terminal activities shown (Zal-
vide et al., 1998) to be essential in activation of pRb
family proteins: an intact “J domain” as well as the LXCXE
motif. Both of these activities have been shown to be
required in cis for transformation in vitro (Srinivasan et
al., 1997; Slinskey et al., 1999). For example, 10TN136
cells might bypass pRb-mediated contact inhibition, con-
tinue to divide after reaching confluence, and simply
detach into the culture medium due to the absence of
some novel proadhesive activity present in full-length
TAg. Such an activity is suggested by both the high
frequency of detached 10TN136 cells as well as the
ability of full-length TAg to promote three-dimensional
growth. However, only approximately 20% of the total
number of 10TN136 cells was found floating in the cul-
ture medium. Thus, simple detachment following LXCXE-
mediated release from pRb-mediated contact inhibition
cannot account for the 250% difference in saturationdensity observed between TAgN136 and full-length TAg
(Fig. 3).
A role for TAgN136-mediated induction of apoptosis
was eliminated as a potential cause for the low transfor-
mation efficiency of TAgN136. Analogous induction of
apoptosis has been reported for adenovirus oncoprotein
E1A which, like TAgN136, possesses an LXCXE motif
(Dyson et al., 1989). Inactivation of pRb by E1A is be-
lieved to activate the transcription of E2F responsive
gene p19ARF and subsequent p19ARF-mediated inacti-
vation of p53 inhibitor MDM2 (Lowe et al., 1993). The
resultant stabilization of p53 was shown to induce p53-
dependent apoptosis in rodent cells (Lowe et al., 1993).
Analysis of cell death in a system in which cells de-
tach spontaneously is complicated by the potential in-
duction of apoptosis due to loss of adhesion alone (Sach-
senmeier et al., 1996; reviewed by Ruoslahti and Reed,
1994). Detached cells might undergo apoptosis simply
from TAgN136-induced detachment, independently of
p53 stabilization. Nevertheless, the possibility of p53-
induced apoptosis in 10TN136 cells was examined by
replating both attached and detached cells after reach-
ing confluence and measuring colony-forming efficiency.
If the TAgN136 was responsible for the induction of cell
death, either before or immediately after detachment,
then a TAgN136-specific decrease in cell survival should
become evident. Apoptosis due to p53-induction should
be counteracted by p53DD. As shown in Fig. 6, the
colony-forming efficiency of 10TN136 cells was not ap-
preciably different from that of control cells or cells ex-
pressing p53DD and TAgN136. An increase in steady
state levels of wild-type p53 was also absent in adherent
cells expressing TAgN136 (Fig. 3).
Data reported here using p53 binding mutants suggest
a contributing role for p53 as a cellular target during
transformation by TAg. The ability of p53DD to abrogate
detachment of 10TN136 cells (Fig. 5) is interesting given
reports of p53-dependent apoptosis following integrin-
specific loss of cell-substrate adhesion (Ilic et al., 1998).
Furthermore, the modest difference (approximately 20%)
in mean saturation density seen between 10TN136 cells
with and without p53DD (Fig. 3) matches the 20% fraction
of 10TN136 cells detached. These data are supportive of
a model whereby a fraction of contact-uninhibited cells
are stimulated to undergo p53-dependent apoptosis dur-
ing an abortive attempt to detach from the culture plate
and grow above the monolayer, as seen with full-length
TAg in Figs. 2 and 3. In fact, the failure of full-length
p53-binding mutant TAg5031 to achieve wild-type TAg
colony-forming efficiency (Fig. 6) suggests a role, albeit
insufficient, for p53 as a contributing cellular target dur-
ing TAg transformation. That is, although failure of
TAg5031 to inactivate p53 may contribute to an interme-
diate survival rate in replated cells (Fig. 6), untargeted
cellular p53 did not disrupt the ability of TAg5031 to both
promote saturation density (Fig. 4) and suppress detach-
a46 SACHSENMEIER AND PIPASment (Fig. 5). Taken together, these data do not support
a primary role for p53-mediated apoptosis in reducing
the saturation density of cells expressing TAgN136.
These results raise at least two crucial questions
regarding pathways leading to cellular transformation.
First, these studies suggest that TAg action upon cellular
p53 is not equivalent to inhibition of p53 activity as
achieved solely by p53DD (Shaulian et al., 1995) alone.
Thus, how do p53 and p53-dependent pathways in cells
expressing p53DD differ from those in the presence of
full-length TAg? This question is intriguing given the
capabilities of both TAg (Rushton et al., 1997; Quartin et
l., 1994) and p53DD (Shualian et al., 1995) to disrupt
both cell-cycle inhibition and transcriptional activation by
endogenous p53.
The second question raised by these experiments is
whether a novel transforming activity requiring the car-
boxy half of TAg is responsible for wild-type TAg trans-
formation. The failure of p53DD to complement the sat-
uration density (Figs. 1 and 3) and focus-formation (Fig.
7) deficiencies of TAgN136 and Tag5031 suggests at
least two possibilities: (1) Some other activity of wild-type
TAg, other than p53-inactivation and deficient in
TAgN136, is required for transformation. One such can-
didate activity is that of the endogenous ATPase of TAg
that maps to the carboxyl terminus of TAg (Clark et al.,
1983). The importance of the ATPase activity of TAg for
transformation is questionable, however, because
ATPase mutant TAg5061 transforms C3H10T1/2 cells and
REF52 cells with wild-type efficiency (Peden et al., 1998).
(2) The inactivation of cellular p53 by wild-type TAg is not
equivalent to that of p53DD. In this case, p53DD could
not make the same contribution to in vitro transformation
made by a full-length wild-type TAg molecule, missing in
TAgN136. Whereas these experiments do not rule out a
need for p53 inactivation along with the putative novel
transforming activity, they strongly suggest a require-
ment of this activity in addition to the p53-binding, pRB-
binding, and J domain-dependent activities already
shown to be present in TAg.
The high saturation density achieved by full-length
p53-binding mutant TAg5031 (Fig. 3) suggests a funda-
mental difference between saturation density and dense
focus formation as measures of in vitro transformation.
Similar to TAgN136, TAg5031 has been shown to be less
efficient than wild-type TAg at dense focus formation
(Srinivasan et al., 1997). Growth above the confluent
monolayer was observed for cells expressing TAg5031
(data not shown) and this ability is likely responsible for
the near wild-type saturation density observed for
TAg5031 (Fig. 3). Further study is needed to determine
why TAg5031 focus-forming efficiency should differ from
its ability to reach high saturation. It is important to note
that in these experiments, saturation density was mea-
sured using stable transfected cells while dense focusassays are performed without selection for drug resis-
tance.
Finally, these experiments introduce an assay system
to screen candidate molecules for involvement in novel
transformation pathways. REF52 cells stably expressing
both p53DD and TAgN136 are unique in that all of the
best characterized cellular targets required for disruption
during oncogenic transformation by TAg (tumor-suppres-
sors pRb, p53, and J-domain-susceptible targets) are
presumably acted upon by either TAgN136 or p53DD.
While phenotypically normal with regard to dense focus
formation, yet highly abnormal for cell-growth control and
apoptotic potential, REF cells expressing TAgN136 and
p53DD offer a powerful and sensitive measure of poten-
tially unknown or subtle transforming molecules and
cellular effectors.
MATERIALS AND METHODS
Cells
C3H10T1/2 cells (ATCC No. CCL-226) and REF52 cells
are immortalized embryo fibroblastic lines derived from
mouse and rat, respectively. These lines were chosen for
their low rate of spontaneous transformation. Cells were
cultured in modified Eagle’s medium (Life Technologies,
Grand Island, NY) supplemented with 10% fetal calf se-
rum (Hyclone, Logan, UT), 100 U/ml penicillin and 100
mg/ml streptomycin (Life Technologies) in a humidified
atmosphere of 5% CO2. Cells were passaged before
reaching confluence except as indicated.
Plasmids
Expression of genomic clones of wild-type SV40 T-
antigen, T-antigen-amino terminal fragment N136 and
p53-binding mutant 5031 were driven by either the Rous
sarcoma virus promoter or the SV40 promoters, and the
constructs have been previously described (Srinivasan
et al., 1997). Each of the constructs express small t-
antigen. Expression of p53DD was driven by the cyto-
megalovirus promoter in plasmid pCMVp53DD and was
a kind gift of Dr. Moshe Oren (The Weizmann Institute,
Rehovot, Israel). All plasmids contained either a neomy-
cin/geneticin or hygromycin resistance gene.
Dense focus assays
Dense focus assays were performed as described
(Srinivasan et al., 1997). Before reaching confluence, 1
mg (C3H10T1/2) or 2 mg (REF52) of circular plasmid DNA
was transfected into cells using lipofectamine (Life Tech-
nologies) according to the manufacturer’s instructions.
Following transfection, cells were split into triplicate
dishes. One-third of the transfected C3H10T1/2 cells
were split into each of three wells of a six-well culture
dish. All of the transfected REF52 cells were split into
three different 75-cm2 culture flasks. Cells were cultured
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47T-ANTIGEN, DOMINANT-NEGATIVE p53, TRANSFORMATIONwith twice-weekly feedings for 3 (C3H10T1/2) or 6 weeks
(REF52) until foci were evident. At this time, cells were
rinsed, fixed with 10% formalin and stained with methyl-
ene blue, and the number of foci in each well was
counted.
Transfection
Transfection of plasmid DNA was performed essen-
tially as described (Srinivasan et al., 1997) and in parallel
with dense focus assays. A total of 1 to 2 mg of DNA was
ransfected as described for dense focus assays and the
ransfected cells were selected for geneticin (G418) or
ygromycin resistance at concentrations of 400 and 200
mg per milliliter of selective medium, respectively.
Immunofluorescence
Cells cultured on glass coverslips were rinsed twice
with phosphate-buffered saline (PBS) at room tempera-
ture, fixed with ice-cold methanol, and frozen at 220°C.
After thawing, cells were permeabilized for 5 min at 37°C
using 0.1% Triton X-100 in PBS and incubated for 1 h at
7°C with primary antibody at a dilution of 1:300 in PBS.
rimary antibodies included monoclonal antibody 419 for
V40 TAg and mutants and monoclonal antibody 421 for
53 and p53DD. Two rinses in PBS were followed by
0-min incubation with fluorescein-conjugated goat anti-
ouse secondary antibody (Sigma Chemical Co., St.
ouis, MO) at 37°C. Next, cells were rinsed twice with
BS, counterstained for 5 min at 37°C with Hoechst
3258 (Roche Molecular Biochemicals, Indianapolis, IN)
t 5 mg per milliliter in PBS, and again rinsed twice with
PBS. Finally, cells were mounted using Vecta Shield
mounting medium (Vector Laboratories, Inc., Burlingame,
CA) and viewed under UV and fluorescent light. Micro-
photographs were taken using a Nikon Axiophot micro-
scope.
Immunoblotting
Cells were grown to the indicated densities, rinsed
twice with ice-cold PBS, and collected by scraping the
plates on ice in Triton lysis buffer (50 mM Tris, pH 7.4,
150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 50 mM
sodium fluoride, 100 mM sodium orthovanadate,
Roche Complete protease inhibitor cocktail, 1 mM pep-
tatin). Lysates were clarified by centrifugation at
4,000g and frozen at 280°C. Protein concentrations
ere determined by the bichinoic acid protein assay
Pierce, Rockford, IL) using bovine serum albumin as
he standard. Immunoblotting was performed as de-
cribed (Srinivasan et al., 1997) with minor modifica-
ions. Briefly, equal portions of protein were resolved
n a 12% polyacrylamide gel containing sodium dode-
yl sulfate, transferred to a polyvinyl difluoride mem-
rane (Millipore, Bedford, MA), and probed using
onoclonal antibodies to TAg (Mab419) or p53MAb421). Specific protein bands were detected using
orseradish peroxidase-conjugated goat anti-mouse
econdary antibody and chemiluminescent substrate
Amersham Pharmacia Biotech, Piscataway, NJ).
onfocal microscopy
Postconfluent cells were rinsed twice with PBS, fixed
ith ice-cold methanol, and treated with 100 mg/ml
RNase A (Roche) for 10 min at 37°C to remove RNA.
Next, cells were stained with nucleic acid intercalating
dye prodidium iodide (Sigma) at 50 mg/ml in PBS. Cells
ere then rinsed once in PBS and mounted using Vecta
hield mounting medium (Vector Laboratories). A z-se-
ies of 250-nm optical slices was taken using a Ziess
SM210 confocal microscope. Digital images were pro-
essed for three-dimensional visualization using the NIH
mage software package.
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